222 related articles for article (PubMed ID: 24448395)
21. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance.
Sakamoto S; McCann RO; Dhir R; Kyprianou N
Cancer Res; 2010 Mar; 70(5):1885-95. PubMed ID: 20160039
[TBL] [Abstract][Full Text] [Related]
22. ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.
Lin D; Watahiki A; Bayani J; Zhang F; Liu L; Ling V; Sadar MD; English J; Fazli L; So A; Gout PW; Gleave M; Squire JA; Wang YZ
Cancer Res; 2008 Jun; 68(11):4352-9. PubMed ID: 18519696
[TBL] [Abstract][Full Text] [Related]
23. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
24. Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer.
Woo J; Santasusagna S; Banks J; Pastor-Lopez S; Yadav K; Carceles-Cordon M; Dominguez-Andres A; Den RB; Languino LR; Pippa R; Lallas CD; Lu-Yao G; Kelly WK; Knudsen KE; Rodriguez-Bravo V; Tewari AK; Prats JM; Leiby BE; Gomella LG; Domingo-Domenech J
J Urol; 2020 Oct; 204(4):691-700. PubMed ID: 32250729
[TBL] [Abstract][Full Text] [Related]
25. Molecular determinants for enzalutamide-induced transcription in prostate cancer.
Yuan F; Hankey W; Wu D; Wang H; Somarelli J; Armstrong AJ; Huang J; Chen Z; Wang Q
Nucleic Acids Res; 2019 Nov; 47(19):10104-10114. PubMed ID: 31501863
[TBL] [Abstract][Full Text] [Related]
26. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
[TBL] [Abstract][Full Text] [Related]
27. A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer.
Vidal SJ; Rodriguez-Bravo V; Quinn SA; Rodriguez-Barrueco R; Lujambio A; Williams E; Sun X; de la Iglesia-Vicente J; Lee A; Readhead B; Chen X; Galsky M; Esteve B; Petrylak DP; Dudley JT; Rabadan R; Silva JM; Hoshida Y; Lowe SW; Cordon-Cardo C; Domingo-Domenech J
Cancer Cell; 2015 Feb; 27(2):223-39. PubMed ID: 25670080
[TBL] [Abstract][Full Text] [Related]
28. Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion.
Hu S; Delorme N; Liu Z; Liu T; Velasco-Gonzalez C; Garai J; Pullikuth A; Koochekpour S
Mol Cancer; 2010 Feb; 9():30. PubMed ID: 20132547
[TBL] [Abstract][Full Text] [Related]
29. Increased nuclear factor I/B expression in prostate cancer correlates with AR expression.
Nanda JS; Awadallah WN; Kohrt SE; Popovics P; Cates JMM; Mirosevich J; Clark PE; Giannico GA; Grabowska MM
Prostate; 2020 Sep; 80(13):1058-1070. PubMed ID: 32692871
[TBL] [Abstract][Full Text] [Related]
30. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
31. Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.
Lin D; Bayani J; Wang Y; Sadar MD; Yoshimoto M; Gout PW; Squire JA; Wang Y
Prostate; 2010 Nov; 70(15):1636-44. PubMed ID: 20564316
[TBL] [Abstract][Full Text] [Related]
32. Dynamic nucleosome landscape elicits a noncanonical GATA2 pioneer model.
Li T; Liu Q; Chen Z; Fang K; Huang F; Fu X; Wang Q; Jin VX
Nat Commun; 2022 Jun; 13(1):3145. PubMed ID: 35672415
[TBL] [Abstract][Full Text] [Related]
33. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
[TBL] [Abstract][Full Text] [Related]
34. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
35. Decreased expression of GATA2 promoted proliferation, migration and invasion of HepG2 in vitro and correlated with poor prognosis of hepatocellular carcinoma.
Li YW; Wang JX; Yin X; Qiu SJ; Wu H; Liao R; Yi Y; Xiao YS; Zhou J; Zhang BH; Fan J
PLoS One; 2014; 9(1):e87505. PubMed ID: 24498120
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target.
Kwok WK; Ling MT; Lee TW; Lau TC; Zhou C; Zhang X; Chua CW; Chan KW; Chan FL; Glackin C; Wong YC; Wang X
Cancer Res; 2005 Jun; 65(12):5153-62. PubMed ID: 15958559
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer metastasis-driving genes: hurdles and potential approaches in their identification.
Chiang YT; Gout PW; Collins CC; Wang Y
Asian J Androl; 2014; 16(4):545-8. PubMed ID: 24589457
[TBL] [Abstract][Full Text] [Related]
38. Expression of STAT3 in Prostate Cancer Metastases.
Don-Doncow N; Marginean F; Coleman I; Nelson PS; Ehrnström R; Krzyzanowska A; Morrissey C; Hellsten R; Bjartell A
Eur Urol; 2017 Mar; 71(3):313-316. PubMed ID: 27344294
[TBL] [Abstract][Full Text] [Related]
39. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.
Zhang H; Pan Y; Zheng L; Choe C; Lindgren B; Jensen ED; Westendorf JJ; Cheng L; Huang H
Cancer Res; 2011 May; 71(9):3257-67. PubMed ID: 21505104
[TBL] [Abstract][Full Text] [Related]
40. GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer.
Robinson JL; Tzou KS; Parker AS; Heckman MG; Wu KJ; Hilton TW; Pisansky TM; Schild SE; Peterson JL; Vallow LA; Buskirk SJ
Br J Radiol; 2017 Jul; 90(1075):20170174. PubMed ID: 28486040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
